发明名称 |
TREATMENT OF OPIATE WITHDRAWAL SYNDROME |
摘要 |
Opiate withdrawal syndrome is treated by administration of a D2 receptor agonist, preferably a selective D2 receptor agonist. Representative compounds include apomorphine, N-allylnoraporphine, pergolide, quinpirole, propylnorapomorphine, bromocryptine, trihydroxyaporphine, methylenedioxy-propylnoraporphine, terguride and hydroxyphenyl-N-propylpiperidine.
|
申请公布号 |
WO9604910(A1) |
申请公布日期 |
1996.02.22 |
申请号 |
WO1994US09116 |
申请日期 |
1994.08.09 |
申请人 |
HAHNEMANN UNIVERSITY;ASTON-JONES, GARY;HARRIS, GLENDA |
发明人 |
ASTON-JONES, GARY;HARRIS, GLENDA |
分类号 |
A61K31/00;A61K31/451;A61K31/473;A61K31/4741;A61K31/4745;A61K31/48;(IPC1-7):A61K31/445 |
主分类号 |
A61K31/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|